Table 2.
Out-of-hospital prescription rates and responses to information provision according to the number of hospital beds
| Number of beds, n | ||||||||
|---|---|---|---|---|---|---|---|---|
| 20–49 beds | 50–99 beds | 100–299 beds | 300–499 beds | ≥ 500 beds | Total | p-value* | ||
| n = 196 | n = 588 | n = 1569 | n = 717 | n = 344 | n = 3414 | |||
| (1) Average out-of-hospital prescription issuance rate (%) | 64.4 | 65.0 | 67.6 | 76.1 | 79.7 | 70.4 | - | |
| (2) Cooperation tool (except community cooperation systems using ICT) for sharing patient information with other healthcare delivery facilities | ||||||||
| (2-A) Information shared with community pharmacies, other hospitals, or long-term nursing homes, n (%) | 64 (32.7) | 247 (42.0) | 719 (45.8) | 439 (61.2) | 221 (64.2) | 1690 (49.5) | < 0.0001 | |
| (2-B) Information shared with community pharmacies (corresponding to 2-B-1 to 2-B-3), n (%) | 38 (19.4) | 168 (28.6) | 580 (37.0) | 393 (54.8) | 208 (60.5) | 1387 (40.6) | < 0.0001 | |
| If “Yes” to the above, the method of sharing information is: | ||||||||
| (2-B-1) Drug summary, n (%) | 24 (63.2) | 103 (61.3) | 333 (57.4) | 168 (42.7) | 73 (35.0) | 701 (50.5) | < 0.0001 | |
| (2-B-2) Tracing report, n (%) | 10 (26.3) | 52 (31.0) | 273 (47.1) | 260 (66.2) | 158 (76.0) | 753 (54.3) | < 0.0001 | |
| (2-B-3) Other, n (%) | 6 (15.8) | 29 (17.3) | 67 (11.6) | 36 (9.2) | 32 (15.4) | 170 (12.3) | 0.39 | |
| (2-C) Information shared with other hospitals (corresponding to 2-C-1 to 2-C-3), n (%) | 54 (27.6) | 211 (35.9) | 555 (35.4) | 293 (40.9) | 128 (37.2) | 1241 (36.4) | 0.007 | |
| If “Yes” to the above, the method of sharing information is: | ||||||||
| (2-C-1) Drug summary, n (%) | 43 (79.6) | 164 (77.7) | 435 (78.4) | 223 (76.1) | 95 (74.2) | 960 (77.4) | 0.30 | |
| (2-C-2) Tracing report, n (%) | 4 (7.4) | 18 (8.5) | 74 (13.3) | 46 (15.7) | 26 (20.3) | 168 (13.5) | 0.0005 | |
| (2-C-3) Other, n (%) | 10 (18.5) | 42 (19.9) | 92 (16.6) | 54 (18.4) | 22 (17.2) | 220 (17.7) | 0.72 | |
| (D) Information shared with long-term nursing homes (corresponding to 2-D-1 to 2-D-3), n (%) | 36 (18.4) | 162 (27.6) | 427 (27.2) | 219 (30.5) | 89 (25.9) | 933 (27.3) | 0.07 | |
| If “Yes” to the above, the method of sharing information is: | ||||||||
| (2-D-1) Drug summary, n (%) | 30 (83.3) | 124 (76.5) | 335 (78.5) | 170 (77.6) | 69 (77.5) | 728 (78.0) | 0.79 | |
| (2-D-2) Tracing report, n (%) | 2 (5.6) | 13 (8.0) | 52 (12.2) | 25 (11.4) | 11 (12.4) | 103 (11.0) | 0.19 | |
| (2-D-3) Other, n (%) | 5 (13.9) | 34 (21.0) | 66 (15.5) | 35 (16.0) | 14 (15.7) | 154 (16.5) | 0.47 | |
| (3) Does your facility share information via a community cooperation system using ICT? | ||||||||
| Yes, n (%) | 13 (6.6) | 28 (4.8) | 165 (10.5) | 116 (16.2) | 90 (26.2) | 412 (12.1) | < 0.0001 | |
| (3-A) If “Yes” to the above, do you check patient information at other healthcare delivery facilities? | ||||||||
| Yes, n (%) | 7 (53.8) | 17 (60.7) | 76 (46.1) | 32 (27.6) | 26 (28.9) | 158 (38.3) | < 0.0001 | |
| (3-B) If “Yes” to the above, place a checkmark next to each relevant information item. | ||||||||
| (3-B-1) Disease name related to consultation/hospitalization, n (%) | 6 (85.7) | 17 (100.0) | 59 (77.6) | 24 (75.0) | 18 (69.2) | 124 (78.5) | 0.04 | |
| (3-B-2) Test parameters related to consultation/hospitalization, n (%) | 3 (42.9) | 9 (52.9) | 58 (76.3) | 18 (56.3) | 16 (61.5) | 104 (65.8) | 0.96 | |
| (3-B-3) Information on allergies that develop, n (%) | 3 (42.9) | 15 (88.2) | 47 (61.8) | 21 (65.6) | 14 (53.8) | 100 (63.3) | 0.37 | |
| (3-B-4) Information on side effects that develop, n (%) | 2 (28.6) | 13 (76.5) | 39 (51.3) | 15 (46.9) | 14 (53.8) | 83 (52.5) | 0.18 | |
| (3-B-5) Information related to adherence, n (%) | 1 (14.3) | 10 (58.8) | 19 (25.0) | 10 (31.3) | 10 (38.5) | 50 (31.6) | 0.84 | |
| (3-B-6) Information related to medicines brought, n (%) | 6 (85.7) | 17 (100.0) | 59 (77.6) | 20 (62.5) | 16 (61.5) | 119 (75.3) | 0.003 | |
| (3-B-7) Information related to discontinued medicines, n (%) | 1 (14.3) | 12 (70.6) | 38 (50.0) | 16 (50.0) | 12 (46.2) | 79 (50.0) | 0.94 | |
| (3-B-8) Information related to medication support (formulation ingenuity), n (%) | 2 (28.6) | 9 (52.9) | 24 (31.6) | 13 (40.6) | 9 (34.6) | 57 (36.1) | 0.86 | |
| (3-B-9) Information/guidance related to outpatient-prescribed pharmacotherapy, n (%) | 3 (42.9) | 7 (41.2) | 30 (39.5) | 13 (40.6) | 10 (38.5) | 63 (39.9) | 0.86 | |
| (3-B-10) Information/guidance on main drugs used during the hospitalization period, n (%) | 5 (71.4) | 11 (64.7) | 45 (59.2) | 18 (56.3) | 14 (53.8) | 93 (58.9) | 0.32 | |
| (3-B-11) Information/guidance on drugs used within 1 week prior to discharge, n (%) | 3 (42.9) | 9 (52.9) | 30 (39.5) | 8 (25.0) | 9 (34.6) | 59 (37.3) | 0.15 | |
| (3-B-12) Guidance provided at discharge, n (%) | 0 (0.0) | 3 (17.6) | 19 (25.0) | 6 (18.8) | 5 (19.2) | 33 (20.9) | 0.71 | |
| (3-B-13) Other, n (%) | 0 (0.0) | 0 (0.0) | 2 (2.6) | 1 (3.1) | 4 (15.4) | 7 (4.4) | 0.01 | |
| (4) Have you introduced a system compatible with the electronic medicine notebook? | ||||||||
| Yes, n (%) | 3 (1.5) | 15 (2.6) | 51 (3.3) | 29 (4.0) | 27 (7.8) | 125 (3.7) | < 0.0001 | |
*The relationship between the number of beds and the proportion of information sharing, use of each tool to share information, information sharing using the community cooperation system via ICT, and introduction of systems compatible with the electronic medicine notebooks was evaluated using the Cochran-Armitage propensity test
ICT: information and communication technology